Dopamine inhibits retinal pathological neovascularization in the oxygen‐induced retinopathy mouse model
The Journal of Pathology · 2026-09 · 270 (1) · 40-54
DOI: 10.1002/path.70080 ↗At a glance
Journal article in The Journal of Pathology, published online on 2026-06-03. Written by Qi Wang and 19 co-authors. Institution: State Key Laboratory of Eye Health, Oujiang Laboratory, National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical Universi…. Major MEDLINE topics: Retinal Neovascularization, Retinopathy of Prematurity, Dopamine. 74 references. The full text is freely available in PubMed Central. Funded by: the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (original language)
Pathological neovascularization is the leading cause of childhood blindness in retinopathy of prematurity (ROP). Anti‐vascular endothelial growth factor agents are commonly used to treat this condition, yet their variable efficacy and off‐target effects demand alternative strategies. Here, we investigated the relationship between retinal dopamine (DA) dynamics and pathological angiogenesis in the oxygen‐induced retinopathy (OIR) mouse model mimicking ROP pathogenesis. We determined the individual effects of apomorphine (APO), a non‐selective DA receptor agonist, and selective agonists or antagonists of dopamine D1 receptor (Drd1) and dopamine D2 receptor (Drd2), on pathological neovascularization. Integrating single‐cell RNA sequencing with Müller cell‐specific Drd2 knockout OIR mice, we identified that Drd2‐mediated signaling in Müller cells orchestrates hypoxia‐inducible factor alpha and vascular endothelial growth factor A biosynthesis in Müller cells during the hypoxic–ischemic phase of OIR. Collectively, OIR‐induced dopaminergic deficiency and impaired Drd2 activity in Müller cells synergistically exacerbate pathological angiogenesis. © 2026 The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Eye Health, Oujiang Laboratory, National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Zhejiang, PR China.
- Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Zhejiang, PR China.
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
- State Key Laboratory of Eye Health, Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
ORCID profiles: Shuai Ouyang, Xiangtian Zhou
Funding
- the National Natural Science Foundation of China
- National Natural Science Foundation of China
Cite
APA
Wang, Q., Shi, J., Ouyang, S., Zhang, T., Yang, H., Zhu, J., Wang, L., Lv, Y., Dong, S., Chen, R., Ling, X., Jiao, S., Dong, M., Yan, W., Yang, J., Yan, B., Chen, J., Qu, J., Zhao, F., & Zhou, X. (2026). Dopamine inhibits retinal pathological neovascularization in the oxygen‐induced retinopathy mouse model. The Journal of Pathology, 270(1), 40-54. https://doi.org/10.1002/path.70080
Vancouver
Wang Q, Shi J, Ouyang S, Zhang T, Yang H, Zhu J, et al. Dopamine inhibits retinal pathological neovascularization in the oxygen‐induced retinopathy mouse model. The Journal of Pathology. 2026;270(1):40-54. doi:10.1002/path.70080
BibTeX
@article{Wang2026,
author = {Wang, Qi and Shi, Jiajia and Ouyang, Shuai and Zhang, Tingting and Yang, Haoran and Zhu, Jiadi and Wang, Luyao and Lv, Yuan and Dong, Sisi and Chen, Ruyi and Ling, Xuemei and Jiao, Shiming and Dong, Mengmeng and Yan, Wenjun and Yang, Jinglei and Yan, Biao and Chen, Jiangfan and Qu, Jia and Zhao, Fei and Zhou, Xiangtian},
title = {Dopamine inhibits retinal pathological neovascularization in the oxygen‐induced retinopathy mouse model},
journal = {The Journal of Pathology},
year = {2026},
volume = {270},
number = {1},
pages = {40--54},
doi = {10.1002/path.70080}
}
EUVIMED